- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Diabetes mellitus type 2 (T2DM)
- Meeting Date: November 2024
- Public Summary Document (PSD) November 2024 PBAC Meeting - (PDF 437KB)
- Public Summary Document (PSD) November 2024 PBAC Meeting - (Word 79KB)
Semaglutide – November 2024
Semaglutide; Solution for injection 2 mg in 3 mL pre-filled pen; Ozempic®
Last updated
30 May 2025